We are live on ! Find out more
BCAX

Bicara Therapeutics
BCAX

69 hedge funds and large institutions have $928M invested in Bicara Therapeutics in 2024 Q3 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

66.96% more ownership

Funds ownership: 0% → 66.96% (+67%)

Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
0.99%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$177M
2
TGA
TPG GP A
Texas
+$76.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$58M
4
OFM
Omega Fund Management
Massachusetts
+$56.2M
5
DM
Deerfield Management
New York
+$45.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$177M +$177M +6,955,993 New
SL
2
Siren LLC
Connecticut
$78.3M +$78.4M +3,072,827 New
TGA
3
TPG GP A
Texas
$76.7M +$76.8M +3,010,425 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$57.9M +$58M +2,273,792 New
OFM
5
Omega Fund Management
Massachusetts
$56.2M +$56.2M +2,204,650 New
DM
6
Deerfield Management
New York
$45.7M +$45.8M +1,795,174 New
B
7
Braidwell
Connecticut
$42.2M +$42.3M +1,657,600 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$39.2M +$39.2M +1,538,934 New
FFM
9
Fairmount Funds Management
Pennsylvania
$32.7M +$32.7M +1,284,169 New
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$30.3M +$30.3M +1,188,191 New
Fidelity International
11
Fidelity International
Bermuda
$25.8M +$25.9M +1,013,853 New
BBA
12
Baker Bros. Advisors
New York
$21.2M +$21.3M +833,333 New
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$20.4M +$20.4M +800,000 New
LGM
14
Logos Global Management
California
$20.4M +$20.4M +800,000 New
DTC
15
Deep Track Capital
Connecticut
$20.3M +$20.3M +796,852 New
Wellington Management Group
16
Wellington Management Group
Massachusetts
$19.5M +$19.5M +763,943 New
AllianceBernstein
17
AllianceBernstein
Tennessee
$18M +$18.1M +708,003 New
Blackstone Inc
18
Blackstone Inc
New York
$16.6M +$16.6M +650,000 New
ACM
19
Aisling Capital Management
New York
$14.5M +$14.5M +568,919 New
FTM
20
First Turn Management
California
$14.3M +$14.3M +562,391 New
RSCM
21
Rock Springs Capital Management
Maryland
$11.4M +$11.4M +445,975 New
VPC
22
Vestal Point Capital
New York
$10.8M +$10.8M +425,000 New
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$9.47M +$9.49M +371,962 New
Millennium Management
24
Millennium Management
New York
$7.63M +$7.64M +299,559 New
WP
25
Woodline Partners
California
$7.08M +$7.09M +277,969 New
1
2 3

BCAX Hedge Fund Activity: Q3 2024 in Review

69 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bicara Therapeutics (BCAX) for Q3 2024, worth a combined $928M.

Buyers outnumbered sellers: 69 funds opened new BCAX positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $177M.

  • 69 institutional investors held Bicara Therapeutics (BCAX) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $928M of Bicara Therapeutics stock for Q3 2024.
  • 69 funds opened new Bicara Therapeutics positions in Q3 2024 and 0 closed out, a net change of +69 holders.
  • The largest Bicara Therapeutics buyer in Q3 2024 was RA Capital Management, an estimated $177M added.

Based on aggregated 13F filings for Q3 2024.